# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615366 | F | In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines | Mus musculus | 7 | cell-based format | Scientific Literature | ||
2. | ALA615367 | F | In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines | Mus musculus | 14 | cell-based format | Scientific Literature | ||
3. | ALA615259 | F | Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
4. | ALA615260 | F | In vitro antitumor activity against 41M cell line. | Homo sapiens | 32 | cell-based format | Scientific Literature | ||
5. | ALA615261 | F | cytotoxicity against 41M cells incubated for 24 hr in MTT assay. | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
6. | ALA615262 | F | Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
7. | ALA615263 | F | In vitro antitumor activity against 41McisR cell line. | Homo sapiens | 32 | cell-based format | Scientific Literature | ||
8. | ALA615264 | F | cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
9. | ALA615687 | F | Inhibitory activity against 3T3 cell line | Mus musculus | 4 | cell-based format | Scientific Literature | ||
10. | ALA619983 | F | In vitro antitumor activity of compound against 7404 cell line (human liver carcinoma cells) | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
11. | ALA618431 | F | Growth inhibition against human 5637 cell lines | Homo sapiens | 19 | cell-based format | Scientific Literature | ||
12. | ALA619131 | F | The compound was tested for cytotoxic potency against A2780 human tumor cell lines. | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
13. | ALA619132 | F | cytotoxicity against A2780 cells incubated for 24 hr in MTT assay. | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
14. | ALA875412 | F | Concentration required to inhibit 50% growth of A2780 human ovarian cancer cells. | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
15. | ALA619146 | F | cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 8 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA619147 | F | Cytotoxic activity in a panel of Human ovarian tumor A2780/CDDP cell line after 96h of drug exposure | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
17. | ALA883794 | F | Cytotoxicity against ovarian carcinoma A2780/cis tumor cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
18. | ALA619152 | F | Cytotoxicity against ovarian carcinoma A2780/cis90 tumor cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
19. | ALA619156 | F | The compound was tested for cytotoxic potency against A2780R human tumor cell lines. | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
20. | ALA619797 | F | Inhibitory effect of Gold(III) complex, CDDP on growth of cisplatin-resistant A2780/R human tumor cell lines | Homo sapiens | 1 | cell-based format | Scientific Literature |